On November 2, 2023, Vivos Therapeutics, Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 USD | +7.18% | -0.48% | -83.20% |
May. 14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Vivos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.20% | 6.74M | |
+75.69% | 12.57B | |
-24.68% | 7.34B | |
+12.58% | 5.39B | |
-16.63% | 4.84B | |
+26.90% | 4.53B | |
-21.82% | 3.91B | |
-22.99% | 2.91B | |
+47.42% | 2.37B | |
-0.37% | 2B |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Vivos Therapeutics, Inc. announced that it has received $4.000003 million in funding